These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26558055)

  • 1. Does intravenous cefuroxime improve the efficacy of ciprofloxacin for preventing infectious complications after transrectal prostate biopsy? A prospective comparative study.
    Rumaihi KA; Majzoub AA; Younes N; Shokeir A
    Arab J Urol; 2012 Dec; 10(4):388-93. PubMed ID: 26558055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital.
    Sewell J; Chow K; De Sousa A; Sapre N; Norris B; Namdarian B; Sinickas V; Huang JG; Anderson P
    BJU Int; 2019 May; 123 Suppl 5():43-46. PubMed ID: 31012990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between ciprofloxacin and trimethoprim-sulfamethoxazole in antibiotic prophylaxis for transrectal prostate biopsy.
    Atılgan D; Gençten Y; Kölükçü E; Kılıç Ş; Uluocak N; Parlaktaş BS; Erdemir F
    Turk J Urol; 2015 Mar; 41(1):27-31. PubMed ID: 26328195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosfomycin trometamol vs ciprofloxacin for antibiotic prophylaxis before transrectal ultrasonography-guided prostate biopsy: A meta-analysis of clinical studies.
    Freitas DMO; Moreira DM
    Arab J Urol; 2019; 17(2):114-119. PubMed ID: 31285922
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.
    Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM
    BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.
    Ekici S; Cengiz M; Turan G; Alış EE
    Int Urol Nephrol; 2012 Feb; 44(1):19-27. PubMed ID: 21547465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
    Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
    Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
    Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
    J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosfomycin antimicrobial prophylaxis for transrectal ultrasound-guided biopsy of the prostate: A prospective randomised study.
    Fahmy AM; Kotb A; Youssif TA; Abdeldiam H; Algebaly O; Elabbady A
    Arab J Urol; 2016 Sep; 14(3):228-33. PubMed ID: 27547466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of faecal ESBL carriers undergoing TRUS-guided prostate biopsy (TRUSPB): role of screening prior to TRUSPB.
    Bhatt NR; Murphy CA; Wall N; McEvoy E; Flynn RJ; Thomas AZ; Manecksha RP; Murphy PG; Smyth LG
    Ir J Med Sci; 2020 Aug; 189(3):817-823. PubMed ID: 31873877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate.
    Ongün S; Aslan G; Avkan-Oguz V
    Urol Int; 2012; 89(4):439-44. PubMed ID: 23006631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibiotic resistance in fecal flora before transrectal ultrasound-guided prostate biopsy and the clinical impact of targeted antibiotic prophylaxis.
    Ozgur A; Asif Y; Gokhan A; Berrin T; Cenk G; Bulent E; Onur D; Meftun C; Haluk V; Hulya C; Turhan C
    Arch Esp Urol; 2017 Dec; 70(10):852-858. PubMed ID: 29205165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem.
    Seitz M; Stief C; Waidelich R; Bader M; Tilki D
    World J Urol; 2017 Nov; 35(11):1681-1688. PubMed ID: 28470334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.
    Singh P; Kumar A; Yadav S; Prakash L; Nayak B; Kumar R; Kapil A; Dogra PN
    Investig Clin Urol; 2017 Sep; 58(5):365-370. PubMed ID: 28868509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates.
    Duplessis CA; Bavaro M; Simons MP; Marguet C; Santomauro M; Auge B; Collard DA; Fierer J; Lesperance J
    Urology; 2012 Mar; 79(3):556-61. PubMed ID: 22386395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can transrectal ultrasound-guided biopsy of the prostate with extended 14-core scheme improve the predictive accuracy of Gleason score and tumor site in prostate cancer treatment?
    Dell'Atti L
    J BUON; 2015; 20(5):1239-43. PubMed ID: 26537070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies.
    Luong B; Danforth T; Visnjevac O; Suraf M; Duff M; Chevli KK
    Urology; 2015 Mar; 85(3):511-6. PubMed ID: 25596154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
    Song W; Choo SH; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG
    Urology; 2014 Nov; 84(5):1001-7. PubMed ID: 25443894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.
    Liss MA; Kim W; Moskowitz D; Szabo RJ
    J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.